Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

315.31
+2.430.78%
Post-market: 315.00-0.3100-0.10%16:59 EDT
Volume:369.98K
Turnover:117.08M
Market Cap:18.97B
PE:34.23
High:318.31
Open:313.66
Low:313.41
Close:312.88
52wk High:330.75
52wk Low:263.00
Shares:60.18M
Float Shares:60.18M
Volume Ratio:1.79
T/O Rate:0.61%
Dividend:4.63
Dividend Rate:1.47%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.96
PE(LYR):7.60

Loading ...

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Yesterday

Halozyme announces Dutch court of the Hague found Merck infringed patents

TIPRANKS
·
Yesterday

AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer

Reuters
·
Yesterday

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Reuters
·
Yesterday

Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc

THOMSON REUTERS
·
Yesterday

Halozyme Therapeutics - Iv Version of Keytruda Remains Available and not Covered by Halozyme's Patent or Court Injunction

THOMSON REUTERS
·
Yesterday

Halozyme Therapeutics - Court Rejects Merck's Arguments That Ep622 Patent is Invalid

THOMSON REUTERS
·
Yesterday

Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda Sc in Multiple European Markets

THOMSON REUTERS
·
Yesterday

Halozyme Therapeutics - Court Orders Msd BV to Stop Keytruda Sc Manufacture and Sale in Eight European Countries

THOMSON REUTERS
·
Yesterday

Halozyme Therapeutics - Injunction Forbids Msd from Facilitating Infringement by Affiliates

THOMSON REUTERS
·
Yesterday

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS
·
Yesterday

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region

GlobeNewswire
·
Yesterday

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419

MT Newswires Live
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

AlzeCure Pharma to Present at Redeye Neurology Day

Reuters
·
Yesterday

Apptly Raises $726,450 in First Tranche of Private Placement for UberDoc Platform

TIPRANKS
·
Yesterday

Will Drug Approvals Change Merck (MRK) Narrative

Simply Wall St.
·
Yesterday

Perrigo Co. PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

UnitedHealth Group (UNH) Expands Medicare Advantage Access, Is The Stock 21% Undervalued?

Simply Wall St.
·
Yesterday

SCWorx Announces Nasdaq Trading to Resume October 7, 2026

GlobeNewswire
·
Yesterday